The Board of Directors of GlaxoSmithKline Plc (GSK) has announced the appointment of Dr Amina Salihu into its Board, as an independent non-executive Director, effective from 28th of May, 2021.
This is according to a disclosure signed by the company’s secretary, Uche Uwechia and sent to the Nigerian Exchange Group Plc (NGX).
Dr Salihu is a renowned consultant, social entrepreneur and feminist. She is a Senior Program Officer with the MacArthur Foundation Africa Office. She is also a member of the Governing Council of Ekiti State University (EKSU) and a coordinator of the Ministry of Finance Technical Working Group on gender, employment and disability inclusion for the Nigeria Agenda 2050 policy development process.
She is an alumna of the prestigious Ahmadu Bello University where she obtained her B.SC. and M.Sc degrees in Political Science. She also obtained further degree (PhD) from the University of Abuja.
Given her background and diverse experiences, the Board of GSK expressed optimism that her addition would bring significant value and diversity to the team.
In another development, the Board also announced the resignation of Mr Uchenna Uwechia as the company secretary and legal director, effective from 1st of June, 2021. His resignation was duly accepted by the Board, after 15 years of meritorious service.
In a bid to fill the vacuum created by the departure of Mr Uwechia, the Board named Mr Frederick Ichekwai as the acting secretary of the company. He will provide leadership for the company secretariat pending further resolutions.
